Many studies have exploited this phenomenon in delivering nano-based chemotherapeutics, such as using HPMA enzyme-linked systems that are specifically cleaved by tumor-specific enzymes, such as cathepsin B [87]. The gene discussed is CTSB; the disease is neoplasm.